Hunter Smith - Jun 30, 2022 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role: Chief Financial Officer
Signature: /s/ Hunter C. Smith
Stock symbol: RYTM
Transactions as of: Jun 30, 2022
Transactions value $: -$30,792
Form type: 4
Date filed: 7/6/2022, 06:08 PM
Previous filing: Jun 9, 2022
Next filing: Dec 29, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RYTM	Common Stock	Options Exercise		+25K	+62.25%		65.2K	Jun 30, 2022	Direct	F1
transaction	RYTM	Common Stock	Sale	-$30.8K	-7.55K	-11.58%	$4.08^*	57.6K	Jul 1, 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RYTM	Restricted Stock Units	Options Exercise	$0	-25K	-100%	$0.00^*	0	Jun 30, 2022	Common Stock	25K		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F2	The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported Restricted Share Units.
F3	On June 30, 2020, the Reporting Person was granted 25,000 restricted stock units, which vested in full on June 30, 2022. The restricted stock units have no expiration date.